NCT02065232View on ClinicalTrials.gov

Sentinel Lymph Node Mapping Post-Injection Site Pain

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Breast Cancer
Interventions
DRUG

Tilmanocept

DRUG

Sulfur Colloid

Trial Locations (1)

92093

University of California, San Diego, San Diego

Sponsors
All Listed Sponsors
collaborator

Navidea Biopharmaceuticals

INDUSTRY

lead

University of California, San Diego

OTHER